EUVIMEDEUVIMED entdecken
Open Access

Optimizing urinary tract infection outcomes: Nitrofurantoin versus fluoroquinolones

Shruti Vihang Brahmbhatt, Samarth Savaliya, Mahavirsingh Rajput, Archana Patel

Bioinformation · 30.06.2026 · 22 (6) · 3777-3781

DOI: 10.6026/973206300223777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 30.06.2026. Verfasst von Shruti Vihang Brahmbhatt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Va…. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rising global prevalence of urinary tract infections and escalating antimicrobial resistance present a critical clinical challenge. Therefore, it is of interest to evaluate the clinical cure rates while minimizing adverse drug reactions (ADRs) and resistance, researchers studied 40 adult patients (80% female) divided into Group I (Nitrofurantoin) and Group II (Fluoroquinolones). Nitrofurantoin achieved a higher clinical cure rate (95%) with 4.75 times greater odds of success than fluoroquinolones (80%). The adverse reaction rate was significantly lower for nitrofurantoin (10% versus 26.7%), though both groups reported similar side effects. Thus, data shows the nitrofurantoin also maintained a lower failure rate (5% versus 15%), supporting its prioritization as a first-line empirical therapy.

Schlagwörter

Stichwörter der Autor:innen

Urinary tract infection (UTI)adverse drug reaction (ADR)antibiotic stewardshipfluroquinolonesnitrofurantoin

Autor:innen und Institutionen

  • Department of Pharmacology, Shrimati Bhikhiben Kanjibhai Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Vadodara- 391760, Gujarat, India.

Zitieren

APA

Brahmbhatt, S. V., Savaliya, S., Rajput, M., & Patel, A. (2026). Optimizing urinary tract infection outcomes: Nitrofurantoin versus fluoroquinolones. Bioinformation, 22(6), 3777-3781. https://doi.org/10.6026/973206300223777

Vancouver

Brahmbhatt SV, Savaliya S, Rajput M, Patel A. Optimizing urinary tract infection outcomes: Nitrofurantoin versus fluoroquinolones. Bioinformation. 2026;22(6):3777-3781. doi:10.6026/973206300223777

BibTeX
@article{Brahmbhatt2026,
  author = {Brahmbhatt, Shruti Vihang and Savaliya, Samarth and Rajput, Mahavirsingh and Patel, Archana},
  title = {Optimizing urinary tract infection outcomes: Nitrofurantoin versus fluoroquinolones},
  journal = {Bioinformation},
  year = {2026},
  volume = {22},
  number = {6},
  pages = {3777--3781},
  doi = {10.6026/973206300223777}
}
Kostenlos starten →